12:00 AM
 | 
Jul 23, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AclarusDx: Completed enrollment

Exonhit completed enrollment of 600 patients complaining of cognitive disorders or memory impairment in the French DIALOG trial evaluating...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >